RUBY
Rubius Therapeutics Inc.
$0.06
Earnings Summary
Revenue | $0Mn |
Net Profits | $-41.29Mn |
Net Profit Margins | -Inf% |
Highlights
Rubius Therapeutics Inc.’s revenue jumped NaN% since last year same period to $0Mn in the Q4 2022. On a quarterly growth basis, Rubius Therapeutics Inc. has generated NaN% jump in its revenue since last 3-months.
Rubius Therapeutics Inc.’s net profit jumped 24.97% since last year same period to $-41.29Mn in the Q4 2022. On a quarterly growth basis, Rubius Therapeutics Inc. has generated 55.57% jump in its net profits since last 3-months.
Rubius Therapeutics Inc.’s net profit margin jumped NaN% since last year same period to -Inf% in the Q4 2022. On a quarterly growth basis, Rubius Therapeutics Inc. has generated NaN% jump in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Rubius Therapeutics Inc. post its latest quarter earnings
EPS Estimate Current Quarter | -0.25 |
EPS Estimate Current Year | -0.25 |
Highlights
Rubius Therapeutics Inc.’s earning per share (EPS) estimates for the current quarter stand at -0.25 - a 3.85% jump from last quarter’s estimates.
Rubius Therapeutics Inc.’s earning per share (EPS) estimates for the current year stand at -0.25.
Key Ratios
Key ratios of the Rubius Therapeutics Inc. post its Q3 2023 earnings
Earning Per Share (EPS) | 0 |
Highlights
Rubius Therapeutics Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2023. This indicates that the Rubius Therapeutics Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-08-18 | -0.25 | 0 | 100% |
2023-05-16 | -0.24 | 0 | 100% |
2023-10-17 | -0.26 | 0 | 100% |
₹0 US Stocks a/c Opening Fee